Peter C. Hou/Brigham and Women's Hospital
Aug 8, 2025, 12:37
Auxora in Severe COVID-19: Phase 2 Trial Reveals D-Dimer Reduction Benefits
Thrombosis Update shared an insightful post on X:
“New article in Thrombosis Update. Findings from a phase 2 trial show that Auxora may help patients with severe COVID-19 by reducing D-dimer levels.”
Read the full article here.
Title: Reduction in D-dimer levels after treatment with Auxora in patients with severe COVID-19 pneumonia
Authors: Peter C. Hou, Joseph Miller, Charles Bruen, Fady Youssef, Michael J. Schnaus, Kathyrn Brouillette, Raul Mendoza-Ayala, Jeffrey Zhang, Kenneth Stauderman, Sudarshan Hebbar
Discover the latest advancements in thrombosis and hemostasis research on Hemostasis Today.
-
Apr 10, 2026, 15:10Jecko Thachil: Should We Consider Air Pollution as a Thrombophilic Marker?
-
Apr 10, 2026, 14:02Pablo Corral: Are Cholesterol and Inflammation Really Equal in Atherosclerosis?
-
Apr 10, 2026, 13:43Mohammed Alo։ How Low Should LDL Go in Secondary Prevention of Cardiovascular Disease
-
Apr 10, 2026, 13:21John Abraham: Telomere Biology Disorders – From Bench to Bedside
-
Apr 10, 2026, 01:19Heghine Khachatryan: When Vascular Fragility Defines Risk – Rethinking Hemostasis in LDS
-
Apr 9, 2026, 21:39Mechanisms of Immune Dysregulation in Immune Thrombocytopenia – JTH
-
Apr 9, 2026, 21:37Arun V J: The Nation Inside the Human Body and Blood Function
-
Apr 9, 2026, 21:36José Antonio García Erce: Fall of While Blood Donation And Apheresis Growth in Spain
-
Apr 9, 2026, 21:34Chokri Ben Lamine: High-Yield Clinical Insights on Carfilzomib-Induced aHUS